The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms

Androgenetic alopecia is one of the most common dermatologic disorders in the daily clinical practice of dermatologists. Despite it is such a common entity, few medications are FDA‐approved for its treatment. Due to this situation dermatologists are often reluctant to try off‐label therapies. This g...

Full description

Saved in:
Bibliographic Details
Published in:JEADV clinical practice 2022-09, Vol.1 (3), p.176-185
Main Authors: Dominguez‐Santas, Miguel, Diaz‐Guimaraens, Borja, Saceda‐Corralo, David, Hermosa‐Gelbard, Angela, Muñoz‐Moreno Arrones, Oscar, Pindado‐Ortega, Cristina, Fernandez‐Nieto, Diego, Jimenez‐Cauhe, Juan, Ortega‐Quijano, Daniel, Suarez‐Valle, Ana, Jaen‐Olasolo, Pedro, Vaño‐Galvan, Sergio
Format: Article
Language:English
Subjects:
Alopecia
androgenetic
Androgens
Baldness
Cardiac arrhythmia
Cell cycle
Drug dosages
Enzymes
FDA approval
Females
Hair loss
Hormones
Males
Patients
Potassium
Testosterone
trichology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Androgenetic alopecia is one of the most common dermatologic disorders in the daily clinical practice of dermatologists. Despite it is such a common entity, few medications are FDA‐approved for its treatment. Due to this situation dermatologists are often reluctant to try off‐label therapies. This guide's purpose is to review the current available therapies for androgenetic alopecia including those off‐label, and to propose treatment algorithms according to the published scientific research.
ISSN:2768-6566
2768-6566
DOI:10.1002/jvc2.53